These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38666296)

  • 21. Comparison of the post-marketing safety profile between influenza and COVID-19 vaccines: An analysis of the vaccine adverse event reporting system.
    Al-Ahmari AK; AlAsmari A; AlKorbi A; Ahmed NJ; Almalki ZS; Alshehri AM; Albassam AA; Alem GM
    Saudi Pharm J; 2022 Aug; 30(8):1137-1142. PubMed ID: 35783675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral Adverse Events Following COVID-19 Vaccination: Analysis of VAERS Reports.
    Riad A; Põld A; Kateeb E; Attia S
    Front Public Health; 2022; 10():952781. PubMed ID: 35899169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trends in reporting embolic and thrombotic events after COVID-19 vaccination: A retrospective, pharmacovigilance study.
    Kan Y; Asada M; Uesawa Y
    PLoS One; 2022; 17(8):e0269268. PubMed ID: 35913955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Cardiovascular Events with COVID-19 Vaccines Using Vaccine Adverse Event Reporting System (VAERS): A Retrospective Study.
    Amir M; Latha S; Sharma R; Kumar A
    Curr Drug Saf; 2024; 19(3):402-406. PubMed ID: 38031796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 - October 2021.
    Moro PL; Olson CK; Clark E; Marquez P; Strid P; Ellington S; Zhang B; Mba-Jonas A; Alimchandani M; Cragan J; Moore C
    Vaccine; 2022 May; 40(24):3389-3394. PubMed ID: 35489985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Postlicensure surveillance of human papillomavirus vaccine using the Vaccine Adverse Event Reporting System, 2006-2017.
    Neha R; Subeesh V; Beulah E; Gouri N; Maheswari E
    Perspect Clin Res; 2020; 11(1):24-30. PubMed ID: 32154146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-world evidence of autoimmune hepatitis following COVID-19 vaccination: A population-based pharmacovigilance analysis.
    Chen C; Xie D; Xiao J
    Front Pharmacol; 2023; 14():1100617. PubMed ID: 37124218
    [No Abstract]   [Full Text] [Related]  

  • 28. Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013-May 31, 2015.
    Haber P; Moro PL; Lewis P; Woo EJ; Jankosky C; Cano M
    Vaccine; 2016 May; 34(22):2507-12. PubMed ID: 27015735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surveillance for poliovirus vaccine adverse events, 1991 to 1998: impact of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine.
    Wattigney WA; Mootrey GT; Braun MM; Chen RT
    Pediatrics; 2001 May; 107(5):E83. PubMed ID: 11331733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS).
    Shimabukuro TT; Nguyen M; Martin D; DeStefano F
    Vaccine; 2015 Aug; 33(36):4398-405. PubMed ID: 26209838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety monitoring of bivalent mRNA COVID-19 vaccine among pregnant persons in the vaccine adverse event reporting System - United States, September 1, 2022 - March 31, 2023.
    Moro PL; Carlock G; Fifadara N; Habenicht T; Zhang B; Strid P; Marquez P
    Vaccine; 2024 Apr; 42(9):2380-2384. PubMed ID: 38462432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Facial nerve palsy following the administration of COVID-19 mRNA vaccines: analysis of a self-reporting database.
    Sato K; Mano T; Niimi Y; Toda T; Iwata A; Iwatsubo T
    Int J Infect Dis; 2021 Oct; 111():310-312. PubMed ID: 34492394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-life safety profile of mRNA vaccines for COVID-19: An analysis of VAERS database.
    Santi Laurini G; Montanaro N; Broccoli M; Bonaldo G; Motola D
    Vaccine; 2023 May; 41(18):2879-2886. PubMed ID: 37024412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing Signal Management in a Vaccine Adverse Event Reporting System: A Proof-of-Concept with COVID-19 Vaccines Using Signs, Symptoms, and Natural Language Processing.
    Dong G; Bate A; Haguinet F; Westman G; Dürlich L; Hviid A; Sessa M
    Drug Saf; 2024 Feb; 47(2):173-182. PubMed ID: 38062261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Signal Detection of Adverse Events Following Pneumococcal Vaccines from the Korea Adverse Event Reporting System Database, 2005-2016.
    Kim KS; Oh IS; Kim HJ; Song I; Park MS; Shin JY
    Yonsei Med J; 2020 Mar; 61(3):243-250. PubMed ID: 32102125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The temporal relationship between RotaTeq immunization and intussusception adverse events in the Vaccine Adverse Event Reporting System (VAERS).
    Geier DA; King PG; Sykes LK; Geier MR
    Med Sci Monit; 2012 Feb; 18(2):PH12-17. PubMed ID: 22293889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ocular Complications after COVID-19 Vaccination, Vaccine Adverse Event Reporting System.
    Nyankerh CNA; Boateng AK; Appah M
    Vaccines (Basel); 2022 Jun; 10(6):. PubMed ID: 35746549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Understanding vaccine safety information from the Vaccine Adverse Event Reporting System.
    Varricchio F; Iskander J; Destefano F; Ball R; Pless R; Braun MM; Chen RT
    Pediatr Infect Dis J; 2004 Apr; 23(4):287-94. PubMed ID: 15071280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infant immunization with acellular pertussis vaccines in the United States: assessment of the first two years' data from the Vaccine Adverse Event Reporting System (VAERS).
    Braun MM; Mootrey GT; Salive ME; Chen RT; Ellenberg SS
    Pediatrics; 2000 Oct; 106(4):E51. PubMed ID: 11015546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adverse Events Following COVID-19 Vaccination in Adolescents: Insights From Pharmacovigilance Study of VigiBase.
    Kim DH; Kim JH; Oh IS; Choe YJ; Choe SA; Shin JY
    J Korean Med Sci; 2024 Mar; 39(8):e76. PubMed ID: 38442719
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.